Applications of Methyl L-Lysinate Dihydrochloride in Industrial Manufacturing

As the original manufacturer, we supply high-purity Methyl L-Lysinate Dihydrochloride for industrial users in distinct process-driven sectors. Our focus supports advanced downstream manufacturing, with full transparency in compliance, batch reproducibility, and validated integration steps across several key industrial specializations.

1. Pharmaceutical Intermediate for Peptide Drug Synthesis

Major peptide manufacturing operations use our raw material as a protected lysine building block or as an intermediate in solid-phase peptide synthesis. It provides an efficient entry point for selective methyl ester protection, essential for robust coupling steps and to achieve high peptide purity. Peptide drug producers rely on precise raw material specifications and traceability from our batches to meet strict market registration requirements.

Industry compliance standards

• ICH Q7 (Good Manufacturing Practice for Active Pharmaceutical Ingredients)
• European Pharmacopoeia (Ph. Eur.) monographs relevant to peptide synthesis
• FDA 21 CFR Part 210/211 (US cGMP for drugs)
• USP–NF where applicable for intermediates

Typical usage ratio

• 0.9–1.2 equivalents relative to core amino acid content in sequence elongation
• Ratio adjusted based on solid-phase resin loading and stepwise yield performance

Downstream process integration

• Introduced during SPPS chain elongation after base deprotection
• Engages in segment coupling amid ester-functionalized resin supports
• Deprotection and side-chain handling completed during final-stage process
• Purified by preparative HPLC before downstream packaging or formulation

Final product types

• Active pharmaceutical ingredient (API) peptides
• Peptide-based injectable formulations
• Custom therapeutic peptides for clinical trials
• Peptidomimetic compound libraries

2. Advanced Nutritional Formulations for Parenteral Nutrition

Major medical nutrition manufacturers use this ingredient as a lysine source with improved solubility and stability for clinical amino acid blends. It supports precise nitrogen balance in total parenteral nutrition (TPN) solutions, especially where strict control over endotoxin and trace element impurities is mandated by hospital and clinical applications. Compounding centers favor this form due to its suitability for sterile preparation processes.

Industry compliance standards

• USP 26–NF 21 parenteral amino acid requirements
• ISO 13408 for aseptic processing
• EU Directive 2001/83/EC for medicinal nutritionals
• FDA cGMP for large-volume parenterals (21 CFR 212)

Typical usage ratio

• 2.5–8.0 g/L as part of total TPN amino acid blend
• Exact content tailored based on patient-specific protein balancing

Downstream process integration

• Injected into bulk amino acid solution pre-mixing lines
• Filtered under sterile conditions before bag filling
• Final endotoxin and sterility checks prior to release
• Supplied as part of GMP-validated batch documentation

Final product types

• TPN solution bags for injection
• Neonatal and adult parenteral amino acid mixtures
• Specialized medical nutrition products
• MODS (multiple organ dysfunction) clinical nutrition solutions

3. Chemical Modification Reagent for Specialty Polymers

Chemical manufacturers processing functional polyamides or biopolymers incorporate our raw material to introduce lysine-derived side chains through esterification and amidation. This step modulates polymer surface charge, hydrophilicity, and reactivity, supporting applications in advanced coatings, hydrogels, and biomedical polymers. The methyl ester group ensures controlled reactivity under mild processing conditions.

Industry compliance standards

• ISO 9001:2015 for polymer manufacturing processes
• REACH Annex IV for registration exemptions (where applicable)
• DIN EN ISO 10993 for medical polymer biocompatibility (if used for devices)
• RoHS for electronic coating applications

Typical usage ratio

• 0.05–0.3 mol per mol of repeat unit in modification reaction
• Adjusted for degree of substitution and polymer backbone composition

Downstream process integration

• Added during side-chain grafting or backbone functionalization steps post-polymerization
• Solubilized in suitable solvent for homogeneous reaction kinetics
• Reaction monitored by NMR or HPLC for substitution control
• Residual material removed during purification or precipitation

Final product types

• Charged or hydrophilic functional polyamides
• Hydrogel matrices for biosensor platforms
• Biocompatible medical coatings
• Smart polymer films for diagnostics

4. Chiral Building Block for Fine Chemical Synthesis

Fine chemical producers leverage this raw material’s enantiomeric purity in asymmetric synthesis of intermediates for agrochemical and specialty chemical manufacturing. The methyl ester facilitates smooth conversion into downstream targets via selective hydrolysis, reductive amination, or ring-closing transformations, making it valuable in custom synthesis pipelines focused on high-value chiral molecules.

Industry compliance standards

• ISO 9001:2015 certified quality management
• Applicable OECD/EU REACH chemical regulations
• GMP for starting materials when producing actives
• SAR (Substance Assessment Report) submission for new chemical entities

Typical usage ratio

• 0.5–1.5 equivalents relative to core substrate in chiral synthesis
• Efficiency tuned by the required yield and conversion profile

Downstream process integration

• Charged to batch reactors as chiral precursor or auxiliary
• Modified by standard ester cleavage or amide coupling
• Monitored via HPLC-UV or chiral GC for enantiopurity
• Isolated and purified before subsequent reaction integration

Final product types

• Chiral pharmaceutical intermediates
• Stereochemically defined agrochemical actives
• Advanced ligands and auxiliaries for catalysts
• Custom molecules for specialty chemical markets

5. Analytical Reference Standard Production

Researchers and QC laboratories use this compound to calibrate and validate analytical instruments, especially in multi-residue amino acid quantification by HPLC and MS. The compound ensures stability and consistency in reference solution preparation, delivering traceable purity for test method validation. This use demands tight impurity profile control and batch-to-batch reproducibility from the manufacturing side.

Industry compliance standards

• ISO/IEC 17025 for laboratory competence
• USP Reference Standards program guidelines
• ISO Guide 34 for reference material producers
• Traceability to NIST SRMs when applicable

Typical usage ratio

• 10–50 mg/kg in aqueous or organic calibration solution
• Adjusted based on instrument sensitivity and expected analyte concentration range

Downstream process integration

• Dissolved in buffer or mobile phase for standard curve creation
• Batched and aliquoted under controlled humidity and light exposure
• Stability testing conducted for expiry documentation
• Integrated as a control in ongoing laboratory proficiency testing

Final product types

• Certified reference materials (CRMs)
• Analytical calibration standards
• Internal standards for HPLC or LC-MS/MS
• Validation kits for pharmaceutical and bioscience laboratories